Novozymes A/S banner

Novozymes A/S
SWB:NZM2

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
SWB:NZM2
Watchlist
Price: 48.75 EUR -1.28%
Market Cap: €13.5B

Wall Street
Price Targets

NZM2 Price Targets Summary
Novozymes A/S

Wall Street analysts forecast NZM2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NZM2 is 63.58 EUR with a low forecast of 51.25 EUR and a high forecast of 78.52 EUR.

Lowest
Price Target
51.25 EUR
5% Upside
Average
Price Target
63.58 EUR
30% Upside
Highest
Price Target
78.52 EUR
61% Upside
Novozymes A/S Competitors:
Price Targets

Revenue
Forecast

3% / Year
Past Growth
-55% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
3% / Year
Past Growth
-55% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

Operating Income
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Novozymes A/S

Net Income
Forecast

0% / Year
Past Growth
-56% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
0% / Year
Past Growth
-56% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NZM2's stock price target?
Price Target
63.58 EUR

According to Wall Street analysts, the average 1-year price target for NZM2 is 63.58 EUR with a low forecast of 51.25 EUR and a high forecast of 78.52 EUR.

What is Novozymes A/S's Revenue forecast?
Projected CAGR
-55%

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

What is Novozymes A/S's Net Income forecast?
Projected CAGR
-56%

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett